LONDON, Ontario--(BUSINESS WIRE)--Stellar Pharmaceuticals Inc., (TSXV:SLX)(OTC BB:SLXCF.OB) (“Stellar”) (the “Company”), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets announced today it has held its annual shareholder meeting in Toronto, Ontario on Wednesday, June 20, 2007. Stellar’s CEO, Peter Riehl, reported on the Company’s progress over the past year as well as highlighting accomplishments over the last 5 years.
